US Patent 9982060 Bi-specific fusion proteins
Patent 9982060 was granted and assigned to Merrimack Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 24, 2014
0
Date of Patent
May 29, 2018
0
Patent Applicant
Patent Application Number
14187728
0
Patent Citations Received
Patent Inventor Names
Ulrik Bjerl Nielsen
0
Birgit Schoeberl
0
Brian Harms
0
Bryan Linggi
0
Byron DeLaBarre
0
Matthew Onsum
0
Thomas Wickham
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9982060 Bi-specific fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
